Ben Tre Pharmaceutical JSC (STC:DBT) Revenue: ₫ Mil (TTM As of . 20)


STC:DBT Ben Tre Pharmaceutical JSC STC:DBT
13 GF Score
Price ₫12,700.00
! 1 Warning Sign
View Full Analysis

What is Ben Tre Pharmaceutical JSC Revenue?

Ben Tre Pharmaceutical JSC STC:DBT +0.79% 13 Revenue is ₫ Mil as of . 20. GuruFocus rates STC:DBT with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Ben Tre Pharmaceutical JSC's revenue for the six months ended in . 20 was ₫0.00 Mil. Ben Tre Pharmaceutical JSC does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in . 20. Ben Tre Pharmaceutical JSC's Revenue per Share for the six months ended in . 20 was ₫0.00. Ben Tre Pharmaceutical JSC does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Ben Tre Pharmaceutical JSC  (STC:DBT) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Ben Tre Pharmaceutical JSC Revenue Related Terms

Ben Tre Pharmaceutical JSC Revenue Historical Data

* Premium members only.

The historical data trend for Ben Tre Pharmaceutical JSC's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ben Tre Pharmaceutical JSC Revenue Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
Revenue

Ben Tre Pharmaceutical JSC Semi-Annual Data
Revenue

STC:DBT vs ZTS, UTHR, VTRS: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ben Tre Pharmaceutical JSC's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ben Tre Pharmaceutical JSC Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ben Tre Pharmaceutical JSC's Revenue distribution charts can be found below:

* The bar in red indicates where Ben Tre Pharmaceutical JSC's Revenue falls into.


STC:DBT
13GF Score
Ben Tre Pharmaceutical JSC STC:DBT
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ben Tre Pharmaceutical JSC Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ₫ Mil mean?
Ben Tre Pharmaceutical JSC (STC:DBT) has a Revenue of ₫ Mil as of . 20. Revenue is the total amount a company generates as sales through its operations. View historical data on Ben Tre Pharmaceutical JSC and its competitors.
Is Ben Tre Pharmaceutical JSC's Revenue too high?
Ben Tre Pharmaceutical JSC's current Revenue is ₫ Mil. Overall, Ben Tre Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Ben Tre Pharmaceutical JSC's Revenue compare to ZTS and UTHR?
Ben Tre Pharmaceutical JSC's Revenue of ₫ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Ben Tre Pharmaceutical JSC and its competitors. Ben Tre Pharmaceutical JSC's current Revenue is ₫ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ben Tre Pharmaceutical JSC stock overvalued right now?
Ben Tre Pharmaceutical JSC (STC:DBT) has a current Revenue of ₫ Mil. The current Revenue is ₫ Mil. Ben Tre Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Ben Tre Pharmaceutical JSC (STC:DBT), the current Revenue is ₫ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ben Tre Pharmaceutical JSC Business Description

Address No. 6A3, National Highway 60, Phu Tan Ward, Vinh Long Province, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is based in Vietnam. The company is engaged in trading in pharmaceuticals, functional foods, vaccines, cosmetics, medical equipment, & medical machinery. It is also engaged in the Import and export of testing chemicals & biological products, Manufacturing medicines for human treatment, producing pharmaceuticals, chemicals, and medicinal herbs, and Leasing warehouses and premises.
13GF Score

Get the complete analysis for STC:DBT

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫12,700.00
Price